The Tokyo Ginza Wellness & Aging Clinic of Mirai Medical Group have achieved the measurement of nicotinamide adenine dinucleotide (NAD) contained in human peripheral blood mononuclear cells. Both institutions receive medical support by Mirailab Bioscience Inc.
This is the first time in the world for a private medical institution to measure NAD, a marker of aging, before and after taking nicotinamide mononucleotide (NMN). This information is useful for daily health management. For example, it can help establish how much NMN should take a certain individual in order to maintain NAD levels.